nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—NR3C2—Gene Expression—SF3B1—ocular cancer	0.00832	0.00832	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00804	0.00804	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—E2F5—ocular cancer	0.008	0.008	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—TFDP1—ocular cancer	0.00785	0.00785	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.00779	0.00779	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PSPH—ocular cancer	0.00708	0.00708	CbGpPWpGaD
Betamethasone—CYP19A1—Ovarian Infertility Genes—CDKN1B—ocular cancer	0.00695	0.00695	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—HRAS—ocular cancer	0.00682	0.00682	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.00642	0.00642	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—ocular cancer	0.00635	0.00635	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00629	0.00629	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MAML2—ocular cancer	0.00623	0.00623	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—E2F5—ocular cancer	0.00617	0.00617	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—E2F4—ocular cancer	0.00605	0.00605	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.00602	0.00602	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00599	0.00599	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—RBL1—ocular cancer	0.00593	0.00593	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—E2F1—ocular cancer	0.00589	0.00589	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—EIF1AX—ocular cancer	0.00586	0.00586	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.00581	0.00581	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.00575	0.00575	CbGpPWpGaD
Betamethasone—CYP19A1—Tryptophan metabolism—MDM2—ocular cancer	0.00569	0.00569	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDK6—ocular cancer	0.00549	0.00549	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00543	0.00543	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.00534	0.00534	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00533	0.00533	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00523	0.00523	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SF3B1—ocular cancer	0.00507	0.00507	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—E2F5—ocular cancer	0.00488	0.00488	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—ocular cancer	0.0048	0.0048	CbGpPWpGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—ocular cancer	0.00479	0.00479	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—E2F4—ocular cancer	0.00478	0.00478	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00478	0.00478	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RPL39—ocular cancer	0.00469	0.00469	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RBL1—ocular cancer	0.00469	0.00469	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.00466	0.00466	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—HDAC1—ocular cancer	0.00456	0.00456	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00448	0.00448	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00446	0.00446	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00442	0.00442	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.0043	0.0043	CbGpPWpGaD
Betamethasone—CYP19A1—FSH signaling pathway—AKT1—ocular cancer	0.00422	0.00422	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00409	0.00409	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RBBP4—ocular cancer	0.00406	0.00406	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.0038	0.0038	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MAML2—ocular cancer	0.0038	0.0038	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—TFDP1—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00371	0.00371	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—E2F1—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00359	0.00359	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—EIF1AX—ocular cancer	0.00357	0.00357	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—E2F5—ocular cancer	0.00357	0.00357	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—E2F4—ocular cancer	0.0035	0.0035	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—EP300—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00347	0.00347	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—RBL1—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—MDM2—ocular cancer	0.00334	0.00334	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00327	0.00327	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0032	0.0032	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.00316	0.00316	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00314	0.00314	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CCND1—ocular cancer	0.00312	0.00312	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00305	0.00305	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—CDKN1B—ocular cancer	0.00305	0.00305	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAML2—ocular cancer	0.003	0.003	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—E2F5—ocular cancer	0.00297	0.00297	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00297	0.00297	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—E2F1—ocular cancer	0.00296	0.00296	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SF3B1—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—E2F4—ocular cancer	0.00291	0.00291	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—EP300—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—RBL1—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—RPL39—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—CDKN1A—ocular cancer	0.00281	0.00281	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—HDAC1—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—TFDP1—ocular cancer	0.00276	0.00276	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PSPH—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—RB1—ocular cancer	0.00256	0.00256	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00256	0.00256	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—TGFB1—ocular cancer	0.00256	0.00256	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDK2—ocular cancer	0.00255	0.00255	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MYC—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—ocular cancer	0.0025	0.0025	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00249	0.00249	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—RBBP4—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDK4—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—TFDP1—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GNA11—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MAML2—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—HDAC1—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SAG—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN1B—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—RB1—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GNAQ—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EIF1AX—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CCND1—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN1A—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—CDKN2B—ocular cancer	0.00197	0.00197	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—E2F5—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—E2F4—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—EP300—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RBL1—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—CDKN1A—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—HRAS—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAML2—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PSPH—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—E2F5—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—E2F4—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RPL39—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RBL1—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—AKT1—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—E2F3—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—HDAC1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MYC—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TGFB1—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TFDP1—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RBBP4—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SAG—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—HDAC1—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—TFDP1—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PSPH—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Betamethasone—PTGS2—Disease—E2F5—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CDKN2B—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAML2—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Betamethasone—PTGS2—Disease—E2F4—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RPL39—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RBL1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAML2—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GNA11—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000978	0.000978	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000976	0.000976	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—ocular cancer	0.000965	0.000965	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GNAQ—ocular cancer	0.000964	0.000964	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TFDP1—ocular cancer	0.000936	0.000936	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HDAC1—ocular cancer	0.000869	0.000869	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000863	0.000863	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000851	0.000851	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000849	0.000849	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNA11—ocular cancer	0.000813	0.000813	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000788	0.000788	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN2B—ocular cancer	0.000779	0.000779	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HDAC1—ocular cancer	0.000773	0.000773	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—ocular cancer	0.000762	0.000762	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNAQ—ocular cancer	0.000756	0.000756	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PSPH—ocular cancer	0.000754	0.000754	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000752	0.000752	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—EP300—ocular cancer	0.000744	0.000744	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAML2—ocular cancer	0.000744	0.000744	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000727	0.000727	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—E2F1—ocular cancer	0.000715	0.000715	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000699	0.000699	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CDKN2B—ocular cancer	0.000693	0.000693	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000692	0.000692	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00061	0.00061	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000603	0.000603	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000601	0.000601	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00059	0.00059	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—ocular cancer	0.000558	0.000558	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HDAC1—ocular cancer	0.000544	0.000544	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNA11—ocular cancer	0.000543	0.000543	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—ocular cancer	0.000529	0.000529	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNAQ—ocular cancer	0.000505	0.000505	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000495	0.000495	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—ocular cancer	0.000487	0.000487	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—ocular cancer	0.00045	0.00045	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MDM2—ocular cancer	0.000432	0.000432	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000418	0.000418	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000408	0.000408	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNA11—ocular cancer	0.000385	0.000385	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—ocular cancer	0.000376	0.000376	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1A—ocular cancer	0.000364	0.000364	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNAQ—ocular cancer	0.000358	0.000358	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—ocular cancer	0.000346	0.000346	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—ocular cancer	0.000322	0.000322	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MDM2—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNA11—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1A—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—ocular cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—ocular cancer	7.78e-05	7.78e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—ocular cancer	4.79e-05	4.79e-05	CbGpPWpGaD
